Canada markets closed

ChemoCentryx, Inc. (CCXI)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
58.80+3.82 (+6.95%)
At close: 4:00PM EDT
Currency in USD

Valuation Measures

Market Cap (intraday) 54.05B
Enterprise Value 33.6B
Trailing P/E N/A
Forward P/E 1-42.00
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)53.25
Price/Book (mrq)9.61
Enterprise Value/Revenue 347.31
Enterprise Value/EBITDA 6-116.32

Trading Information

Stock Price History

Beta (5Y Monthly) 1.68
52-Week Change 3659.69%
S&P500 52-Week Change 314.01%
52 Week High 365.43
52 Week Low 37.61
50-Day Moving Average 354.17
200-Day Moving Average 354.87

Share Statistics

Avg Vol (3 month) 3577.28k
Avg Vol (10 day) 3605.98k
Shares Outstanding 568.89M
Float 47.82M
% Held by Insiders 128.93%
% Held by Institutions 167.08%
Shares Short (Sep. 29, 2020) 45.48M
Short Ratio (Sep. 29, 2020) 48.04
Short % of Float (Sep. 29, 2020) 411.80%
Short % of Shares Outstanding (Sep. 29, 2020) 47.95%
Shares Short (prior month Aug. 30, 2020) 45.27M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2019
Most Recent Quarter (mrq)Jun. 29, 2020

Profitability

Profit Margin -39.18%
Operating Margin (ttm)-41.39%

Management Effectiveness

Return on Assets (ttm)-5.10%
Return on Equity (ttm)-12.10%

Income Statement

Revenue (ttm)76.08M
Revenue Per Share (ttm)1.26
Quarterly Revenue Growth (yoy)589.30%
Gross Profit (ttm)-34.15M
EBITDA -30.94M
Net Income Avi to Common (ttm)-29.81M
Diluted EPS (ttm)-0.50
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)504.62M
Total Cash Per Share (mrq)7.32
Total Debt (mrq)53.08M
Total Debt/Equity (mrq)12.60
Current Ratio (mrq)9.00
Book Value Per Share (mrq)6.12

Cash Flow Statement

Operating Cash Flow (ttm)-82.73M
Levered Free Cash Flow (ttm)-6.34M